Miras-amanat-e19601:04:57 Min Apr 2026

This report focuses on the study titled which was published in the journal Medicine in 2020 under the reference e19601 .

The primary goal of this research was to investigate the incidence, triggers, and long-term outcomes of status epilepticus (SE) within the specific context of autoimmune encephalitis (AE). While 80% of AE patients generally recover well (Modified Rankin Score 0–2) with early immunotherapy, the subset that develops SE faces significantly higher risks. Miras-Amanat-E19601:04:57 Min

Seizures that continue or relapse 24 hours after the administration of intravenous anesthetic treatment. 3. Clinical Findings This report focuses on the study titled which

Defined as persistent clinical or electroencephalographic seizures despite adequate doses of benzodiazepines and standard antiepileptic drugs. Seizures that continue or relapse 24 hours after

Evaluation of Predisposing Factors and Prognostic Risk Factors for Status Epilepticus (SE) in Patients with Autoimmune Encephalitis (AE). 1. Core Objective

Indicates SE that requires immediate medical intervention.